Role of cardiac mast cells in cardiovascular diseases: a review

Li-Min Wang1, Ling-Feng Ye1, Jing Wei2

  • 1Department of Clinical Laboratory, Jiangning Hospital Affiliated to Nanjing Medical University, Nanjing, China.

Peerj
|May 27, 2026
PubMed

Mast cells are multifunctional immune cells that play complex roles in maintaining tissue homeostasis and disease pathogenesis. They are also involved in inflammation, lymphangiogenesis, and tissue remodeling by releasing several inflammatory mediators. Recent preclinical studies highlighting the heterogeneity of cardiac mast cells (CMCs) have intensified the focus on elucidating their functional diversity in both tissue homeostasis and disease pathogenesis. Notably, CMCs can exhibit distinct or even opposite functions to adapt to the dynamic tissue environment. Although the precise mechanisms remains unclear, evidence from animal studies suggests that mast cells participate in human diseases in ways similar to macrophages and other inflammatory cells, either directly or indirectly. In this review, we provide a concise overview of the origin of mast cells and their distribution within cardiac tissue. We also discuss the critical role of activated mast cells in inflammation regression and tissue remodeling following cardiac injury. Furthermore, we highlight the dual roles of CMCs in cardiovascular disease development and their potential implications. Finally, we address future perspectives and directions in basic research, as well as the potential clinical applications of CMCs.

Related Concept Videos

Inflammation01:38

Inflammation

Overview
Myocarditis I: Introduction01:21

Myocarditis I: Introduction

Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs01:25

Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs

Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Myocarditis III: Medical Management01:14

Myocarditis III: Medical Management

Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...